Latest filing published 05 Oct 2017 for Kite Pharma, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Paul L. Jenkinson: trading record in brief
Paul L. Jenkinson is a declared insider of Kite Pharma, Inc., with filings sourced from SEC (Form 4). We count 7 filings; the first trade dates from 22 December 2016 and the latest from 3 October 2017.
On the open market, the record shows 2 purchases worth €230k and 1 sale worth €144k. The net balance comes to €87k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants. 2017 to date brings 2 purchases and 1 sale.
On 5 October 2017 came the latest disclosure, a transaction in Kite Pharma, Inc. The latest purchase dates back some time: it was published 3,469 days ago, on 10 May 2017. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Paul L. Jenkinson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,462 sharesCommon StockSEC:0001209191-17-056219:0
- 3,000 shares@ US$180.0055.1% of flowCommon StockSEC:0001209191-17-056219:1
- 948 shares@ US$179.6617.2% of flowCommon StockSEC:0001209191-17-054195:1
- 2,500 shares0Common StockSEC:0001209191-17-054195:0
- 450 shares@ US$72.573.6% of flowCommon StockSEC:0001209191-17-031197:0Canonical exit: 8 Aug 2017 (T+90)
- 3,000 shares@ US$72.5924.0% of flowCommon StockSEC:0001209191-17-031197:1Canonical exit: 8 Aug 2017 (T+90)
- 6,600 shares0Common StockSEC:0001209191-16-156835:0
7 of 7 declarations
